Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2020

Jan 23, 2020

61176_rns_2020-01-23_1887136b-65fd-45aa-8f52-7492964c3a01.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [146 x 29] intentionally omitted <==

January23, 2020 Electronics CityBangalore 560 100, InT9180 2808 2808F91 80 2852 3423CIN: L24234KA 1978PL
To, To, www.biocon.com
The Manager The Manager
BSELimited National Stock ExchangeofIndia Limited
DepartmentofCorporate Services Corporate Communication Department
Phiroze Jeejeebhoy Towers, ExchangePlaza,Bandra Kurla Complex
Dalal Street,Mumbai-400 001 Mumbai-400 050
Scrip Code - 532523 Scrip Symbol - Biocon
S.No Name Designation EmaiiiDand Contactno
For Biocon Limited Related matters:
1 Ms.KiranMazumdar Shaw Chairperson and ManagingDirector* [email protected]Tel:080-2808-2808
2 Mr. SiddharthMittal CEOand Joint ManagingDirector# [email protected]Tel:080-2808-2808
For Biocon Biologics India Limited Related matters:
1 Ms.KiranMazumdar Shaw Chairperson [email protected]Tel:080-2808-2808
2 Dr.Christiane Hamacher Managing Director andCEO [email protected]Tel:080-2808-2808
3 Mr.MBChinappa Chief Financial Officer mb.china[1[[email protected]Tel:080-2808-2808

==> picture [83 x 80] intentionally omitted <==